Newborn affected by other maternal medication

Preferred Label : Newborn affected by other maternal medication;

Inclusion CIM-10 : Newborn affected by cytotoxic drugs; Newborn affected by cancer chemotherapy;

ICD-10 exclusion note : maternal use of drugs of addiction (P04.4-); fetal hydantoin syndrome (Q86.1); dysmorphism due to warfarin (Q86.2);

Diag associé à un acte (%) : 75.3;

CMA : 4;

Source : OMS;

Date de début : 01/01/1997;

Détails

Origin ID

P041;

UMLS CUI

C4269121;

Excluded by
- Reactions and intoxications due to drugs administered to newborn [ICD-10 category]
False automatic mappings
- cytotoxins [MeSH Descriptor]
ICD-10 exclusion(s)
- Dysmorphism due to warfarin [ICD-10 Sub-category]
- Fetal hydantoin syndrome [ICD-10 Sub-category]
- Newborn affected by maternal use of drugs of addiction [ICD-10 Sub-category]
Semantic type(s)
- Finding [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients